GT200300187A - Compuestos antiinflamatorios de di y trifluoro-triazolo-piridinas - Google Patents
Compuestos antiinflamatorios de di y trifluoro-triazolo-piridinasInfo
- Publication number
- GT200300187A GT200300187A GT200300187A GT200300187A GT200300187A GT 200300187 A GT200300187 A GT 200300187A GT 200300187 A GT200300187 A GT 200300187A GT 200300187 A GT200300187 A GT 200300187A GT 200300187 A GT200300187 A GT 200300187A
- Authority
- GT
- Guatemala
- Prior art keywords
- piridinas
- triazolo
- trifluoro
- inflammatory compounds
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE LA FORMULA GENERAL I EN LA QUE R1,R2,S, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SON POTENTES INHIBIDORES DE QUINASAS MAP, PREFERIBLEMENTE DE LA QUINASA P38, POR LO QUE SON DE UTILIDAD EN UNA AMPLIA VARIEDAD DE CUADROS, TALES COMO LOS INFLAMATORIOS COMO OSTEOARTRITIS, ARTRITIS REUMATOIDE, ENTRE OTRAS PATOLOGIAS DESCRITAS EN LA SOLICITUD.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40717702P | 2002-08-30 | 2002-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200300187A true GT200300187A (es) | 2004-06-23 |
Family
ID=31978432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200300187A GT200300187A (es) | 2002-08-30 | 2003-08-29 | Compuestos antiinflamatorios de di y trifluoro-triazolo-piridinas |
Country Status (17)
Country | Link |
---|---|
US (1) | US7259171B2 (es) |
EP (1) | EP1537108B1 (es) |
JP (1) | JP2006504680A (es) |
AR (1) | AR041078A1 (es) |
AT (1) | ATE414705T1 (es) |
AU (1) | AU2003259438A1 (es) |
BR (1) | BR0313965A (es) |
CA (1) | CA2494754A1 (es) |
DE (1) | DE60324806D1 (es) |
ES (1) | ES2315560T3 (es) |
GT (1) | GT200300187A (es) |
MX (1) | MXPA05002304A (es) |
PA (1) | PA8579601A1 (es) |
PE (1) | PE20040978A1 (es) |
TW (1) | TW200420562A (es) |
UY (1) | UY27961A1 (es) |
WO (1) | WO2004020440A1 (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2264795T3 (es) * | 2003-02-14 | 2007-01-16 | Pfizer Products Inc. | Triazolo-piridinas como compuestos antiinflamatorios. |
WO2006018727A2 (en) * | 2004-08-18 | 2006-02-23 | Pharmacia & Upjohn Company Llc | Triazolopyridine compounds useful for the treatment of inflammation |
ES2301380B1 (es) | 2006-08-09 | 2009-06-08 | Laboratorios Almirall S.A. | Nuevos derivados de 1,7-naftiridina. |
WO2008045393A2 (en) * | 2006-10-11 | 2008-04-17 | Amgen Inc. | Imidazo- and triazolo-pyridine compounds and methods of use therof |
ES2320955B1 (es) | 2007-03-02 | 2010-03-16 | Laboratorios Almirall S.A. | Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida. |
ES2329639B1 (es) | 2007-04-26 | 2010-09-23 | Laboratorios Almirall S.A. | Nuevos derivados de 4,8-difenilpoliazanaftaleno. |
EP1992344A1 (en) | 2007-05-18 | 2008-11-19 | Institut Curie | P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation |
EP2108641A1 (en) | 2008-04-11 | 2009-10-14 | Laboratorios Almirall, S.A. | New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
EP2113503A1 (en) | 2008-04-28 | 2009-11-04 | Laboratorios Almirall, S.A. | New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors |
AU2010276537B2 (en) * | 2009-07-27 | 2015-04-16 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
EP2322176A1 (en) | 2009-11-11 | 2011-05-18 | Almirall, S.A. | New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives |
EP2588197B1 (en) | 2010-07-02 | 2014-11-05 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
TWI510480B (zh) | 2011-05-10 | 2015-12-01 | Gilead Sciences Inc | 充當離子通道調節劑之稠合雜環化合物 |
TW201837023A (zh) | 2011-07-01 | 2018-10-16 | 美商基利科學股份有限公司 | 作為離子通道調節劑之稠合雜環化合物 |
NO3175985T3 (es) | 2011-07-01 | 2018-04-28 | ||
WO2014015056A2 (en) | 2012-07-17 | 2014-01-23 | Washington University | Anti-mucus drugs and uses therefor |
EP2968322B1 (en) | 2013-03-15 | 2018-12-26 | The Trustees of Columbia University in the City of New York | Map kinase modulators and uses thereof |
GB201511382D0 (en) | 2015-06-29 | 2015-08-12 | Imp Innovations Ltd | Novel compounds and their use in therapy |
US20190060286A1 (en) | 2016-02-29 | 2019-02-28 | University Of Florida Research Foundation, Incorpo | Chemotherapeutic Methods |
US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
CA3128468A1 (en) | 2017-10-05 | 2019-04-11 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd |
CN109867617A (zh) * | 2019-04-03 | 2019-06-11 | 南京格亚医药科技有限公司 | 一种4-甲氧基吡咯中间体的制备方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5716972A (en) * | 1993-01-13 | 1998-02-10 | Smithkline Beecham Corporation | Pyridyl substituted imidazoles |
DE69421624T2 (de) * | 1993-09-17 | 2000-07-20 | Smithkline Beecham Corp | Medikamente bindendes protein |
EP1306377A3 (en) * | 1993-11-08 | 2003-05-07 | Smithkline Beecham Corporation | Pyridyl-oxazoles and their use as cytokines inhibitors |
US5717100A (en) * | 1995-10-06 | 1998-02-10 | Merck & Co., Inc. | Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
NZ327044A (en) * | 1996-01-11 | 2000-01-28 | Smithkline Beecham Corp | Substituted imidazole compounds |
ZA97175B (en) * | 1996-01-11 | 1997-11-04 | Smithkline Beecham Corp | Novel substituted imidazole compounds. |
GB9713726D0 (en) | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
JP2002516325A (ja) | 1998-05-26 | 2002-06-04 | スミスクライン・ビーチャム・コーポレイション | 新規な置換イミダゾール化合物 |
US6207687B1 (en) | 1998-07-31 | 2001-03-27 | Merck & Co., Inc. | Substituted imidazoles having cytokine inhibitory activity |
US6350744B1 (en) | 1998-11-20 | 2002-02-26 | Merck & Co., Inc. | Compounds having cytokine inhibitory activity |
PT1140916E (pt) | 1998-12-16 | 2003-03-31 | Aventis Pharma Ltd | Acetais heteroarilo ciclicos |
EP1140083A4 (en) | 1999-01-08 | 2004-01-02 | Smithkline Beecham Corp | NEW CONNECTIONS |
JP2002534468A (ja) | 1999-01-13 | 2002-10-15 | バイエル コーポレイション | p38キナーゼ阻害剤としてのω−カルボキシアリール置換ジフェニル尿素 |
CO5170501A1 (es) * | 1999-04-14 | 2002-06-27 | Novartis Ag | AZOLES SUSTITUIDOS UTILES PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR TNFa eIL-1 Y ENFERMEDADES DEL METABOLISMO OSEO |
MXPA03008142A (es) | 2001-03-09 | 2003-12-12 | Pfizer Prod Inc | Nuevos compuestos antiinflamatorios de bencimidazol. |
ATE323701T1 (de) * | 2001-03-09 | 2006-05-15 | Pfizer Prod Inc | Triazolopyridine als entzündungshemmende mittel |
DE60205974T2 (de) | 2001-04-04 | 2006-06-29 | Pfizer Products Inc., Groton | Neue Benzotriazole mit entzündungshemmender Wirkung |
-
2003
- 2003-08-05 PA PA20038579601A patent/PA8579601A1/es unknown
- 2003-08-19 ES ES03791145T patent/ES2315560T3/es not_active Expired - Lifetime
- 2003-08-19 WO PCT/IB2003/003847 patent/WO2004020440A1/en active Application Filing
- 2003-08-19 EP EP03791145A patent/EP1537108B1/en not_active Expired - Lifetime
- 2003-08-19 MX MXPA05002304A patent/MXPA05002304A/es active IP Right Grant
- 2003-08-19 BR BR0313965-4A patent/BR0313965A/pt not_active IP Right Cessation
- 2003-08-19 CA CA002494754A patent/CA2494754A1/en not_active Abandoned
- 2003-08-19 JP JP2004532622A patent/JP2006504680A/ja not_active Withdrawn
- 2003-08-19 DE DE60324806T patent/DE60324806D1/de not_active Expired - Lifetime
- 2003-08-19 AT AT03791145T patent/ATE414705T1/de not_active IP Right Cessation
- 2003-08-19 AU AU2003259438A patent/AU2003259438A1/en not_active Abandoned
- 2003-08-25 PE PE2003000863A patent/PE20040978A1/es not_active Application Discontinuation
- 2003-08-27 US US10/649,236 patent/US7259171B2/en not_active Expired - Fee Related
- 2003-08-28 AR ARP030103118A patent/AR041078A1/es unknown
- 2003-08-29 TW TW092123952A patent/TW200420562A/zh unknown
- 2003-08-29 UY UY27961A patent/UY27961A1/es not_active Application Discontinuation
- 2003-08-29 GT GT200300187A patent/GT200300187A/es unknown
Also Published As
Publication number | Publication date |
---|---|
US7259171B2 (en) | 2007-08-21 |
PA8579601A1 (es) | 2004-05-07 |
BR0313965A (pt) | 2005-07-19 |
JP2006504680A (ja) | 2006-02-09 |
US20040053958A1 (en) | 2004-03-18 |
EP1537108B1 (en) | 2008-11-19 |
ES2315560T3 (es) | 2009-04-01 |
WO2004020440A1 (en) | 2004-03-11 |
DE60324806D1 (de) | 2009-01-02 |
ATE414705T1 (de) | 2008-12-15 |
EP1537108A1 (en) | 2005-06-08 |
UY27961A1 (es) | 2004-03-31 |
AR041078A1 (es) | 2005-04-27 |
PE20040978A1 (es) | 2004-12-28 |
TW200420562A (en) | 2004-10-16 |
AU2003259438A1 (en) | 2004-03-19 |
MXPA05002304A (es) | 2005-06-08 |
CA2494754A1 (en) | 2004-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200300187A (es) | Compuestos antiinflamatorios de di y trifluoro-triazolo-piridinas | |
GT200300201A (es) | Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesterasa | |
GT200300093A (es) | Inhibidores de metaloproteinasa de heteroariloxi-aril-espiro-pirimidina-2,4,6-triona n-sustituida | |
GT200300240A (es) | Nuevos derivados de dihidropirimido (4,5-d) pirimidinona sustituida por amino, fabricacion y uso de los mismos comoagentes farmaceuticos | |
GT200300226A (es) | 4-piperazinilbencenosulfonilindoles y usos de los mismos | |
GT200400268A (es) | Pirido[2,3-d] pirimidina-2,4-diaminas como inhibidores de pde 2 | |
GT200400032A (es) | Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transformante (tgf) | |
GT200300171A (es) | Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz | |
GT200200234A (es) | Compuestos cristalinos novedosos | |
CY1117639T1 (el) | Φαρμακευτικες συνθεσεις βασιζομενες επι κρυσταλλικης μορφης i της 5-αζακυτιδινης | |
GT200300150A (es) | Inhibidores de quinasas | |
HN2003000094A (es) | Indazoles subtituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion. | |
GT200800258A (es) | Compuestos de pirrolo-pirimidina y sus usos | |
GT200300138A (es) | Moduladores del receptor de glucocorticoides | |
GT200200253A (es) | Heteroaril nitrilos | |
CR11223A (es) | Compuestos de biciclolactama sustituida | |
PA8606901A1 (es) | Derivados de triazolopirimidinas como inhibidores de la glucogeno sintasa quinasa 3 | |
GT200600184A (es) | Derivados de purina | |
PA8596901A1 (es) | Inhibidores de p38 y metodos de uso de ellos | |
GT200300258A (es) | Activadores de ppar | |
PA8592001A1 (es) | Activadores de glocoquinasa heteroaromaticos de seis miembros 5-sustituidos | |
GT200400050A (es) | Compuestos de quinolina y quinoxalina | |
GT200400013A (es) | Compuestos de pirazolotriazina y usos de los mismos | |
GT200600430A (es) | Compuestos de carboxiamina y metodos de uso de los mismos | |
GT200500179AA (es) | Mezclas sinergistas de agentes de antranilamida para el control de plagas de invertebrados |